English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Capitol Breathe Free Sinus & Allergy Centers
Patient Daily
| Oct 23, 2025
Capitol Breathe Free Otolaryngologist: ‘Allergy exacerbations are a common trigger for sinus infections'
Patient Daily
| Aug 12, 2025
Capitol Breathe Free Otolaryngologist on air quality and pollution: ‘These are common triggers for sinus inflammation and sinus infections’
+
Technology/Innovation
Patient Daily
| Mar 4, 2024
Capitol Breathe Free patient: 'When you sleep well, you feel much better about doing everything'
+
Technology/Innovation
Patient Daily
| Jan 11, 2024
Medfluence Advisors' healthcare marketing video series ‘The Pronunciation’ wins Platinum MarCom Award
+
Technology/Innovation
Patient Daily
| Nov 3, 2023
Patient on septoplasty at Capitol Breathe Free: 'They were able to treat me without the need for extensive surgery'
Trending
+
Pharmaceuticals
Patient Daily
| Aug 4, 2026
Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+
Pharmaceuticals
Patient Daily
| Aug 6, 2026
FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+
Regulatory
M. R. Armstrong
| Aug 4, 2026
Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+
Pharmaceuticals
Patient Daily
| Aug 5, 2026
Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes
